Tomaralimab, CAS 1449294-76-1

Product Description: Tomaralimab (OPN-305) is a humanised anti-TLR2 IgG4 monoclonal antibody. Tomaralimab has the potential for the research of Myelodysplastic Syndromes (MDS)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]GuillermoGarcia-ManeroMD, et al. A Clinical Study of Tomaralimab (OPN-305), a Toll-like Receptor 2 (TLR-2) Antibody, in Heavily Pre-Treated Transfusion Dependent Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received and Failed on Prior Hypomethylating Agent (HMA) Therapy. Blood, 2018, 798.

CAS Number: 1449294-76-1

Molecular Weight: N/A

Compound Purity: 96.44

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Toll-like Receptor (TLR)

• Artikelnummer: MEXHY-P99555-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99555-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated